{"id":3483,"date":"2020-08-04T09:49:02","date_gmt":"2020-08-04T09:49:02","guid":{"rendered":"http:\/\/www.enyopharma.com\/fr\/?p=3483"},"modified":"2020-08-04T09:50:11","modified_gmt":"2020-08-04T09:50:11","slug":"nouvelle-release-de-nextprot-avec-les-donnees-dinteractome-humain-denyo-pharma","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/nouvelle-release-de-nextprot-avec-les-donnees-dinteractome-humain-denyo-pharma\/","title":{"rendered":"Nouvelle release de neXtProt avec les donn\u00e9es d&#8217;interactome humain d&#8217;ENYO Pharma"},"content":{"rendered":"<p>ENYO Pharma et le groupe CALIPHO de l&#8217;Institut Suisse de Bioinformatique sont heureux d&#8217;annoncer la release 2020-07-17 de <a href=\"https:\/\/www.nextprot.org\/\">neXtProt<\/a>, qui int\u00e8gre <a href=\"http:\/\/www.enyopharma.com\/fr\/technologie\/interactome-datasets\/\">les donn\u00e9es d&#8217;interactome humain<\/a> cur\u00e9es par l&#8217;entreprise avec l&#8217;\u00e9tiquette &#8220;GOLD&#8221;. Ce jeu de donn\u00e9es comprend 108.000 descriptions d&#8217;interactions prot\u00e9iques issues de 324 publications scientifiques, avec l&#8217;annotation de la m\u00e9thode exp\u00e9rimentale (PSI-MI). Lorsque la s\u00e9quence pr\u00e9cise utilis\u00e9e dans l&#8217;exp\u00e9rience est connue, l&#8217;information a \u00e9t\u00e9 collect\u00e9e et est disponible dans <a href=\"https:\/\/www.nextprot.org\/\">neXtProt<\/a> sous l&#8217;annotation interaction mapping.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ENYO Pharma et le groupe CALIPHO de l&#8217;Institut Suisse de Bioinformatique sont heureux d&#8217;annoncer la release 2020-07-17 de <a href=\"https:\/\/www.nextprot.org\/\">neXtProt<\/a>, qui int\u00e8gre <a href=\"http:\/\/www.enyopharma.com\/fr\/technologie\/interactome-datasets\/\">les donn\u00e9es d&#8217;interactome humain<\/a> cur\u00e9es par l&#8217;entreprise avec l&#8217;\u00e9tiquette &#8220;GOLD&#8221;. Ce jeu de donn\u00e9es comprend 108.000 descriptions d&#8217;interactions prot\u00e9iques issues de 324 publications scientifiques, avec l&#8217;annotation de la m\u00e9thode exp\u00e9rimentale (PSI-MI). Lorsque la s\u00e9quence pr\u00e9cise utilis\u00e9e dans l&#8217;exp\u00e9rience est connue, l&#8217;information a \u00e9t\u00e9 collect\u00e9e et est disponible dans <a href=\"https:\/\/www.nextprot.org\/\">neXtProt<\/a> sous l&#8217;annotation interaction mapping.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/www.enyopharma.com\/fr\/nouvelle-release-de-nextprot-avec-les-donnees-dinteractome-humain-denyo-pharma\/\">Lire la suite&nbsp;&raquo;<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[21],"tags":[],"class_list":["post-3483","post","type-post","status-publish","format-standard","hentry","category-latest-news-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.enyopharma.com\/fr\/category\/latest-news-fr\/\" rel=\"category tag\">Br\u00e8ves<\/a>","rttpg_excerpt":"ENYO Pharma et le groupe CALIPHO de l&#8217;Institut Suisse de Bioinformatique sont heureux d&#8217;annoncer la release 2020-07-17 de neXtProt, qui int\u00e8gre les donn\u00e9es d&#8217;interactome humain cur\u00e9es par l&#8217;entreprise avec l&#8217;\u00e9tiquette &#8220;GOLD&#8221;. Ce jeu de donn\u00e9es comprend 108.000 descriptions d&#8217;interactions prot\u00e9iques issues de 324 publications scientifiques, avec l&#8217;annotation de la m\u00e9thode exp\u00e9rimentale (PSI-MI). Lorsque la s\u00e9quence&hellip;","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3483","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=3483"}],"version-history":[{"count":2,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3483\/revisions"}],"predecessor-version":[{"id":3485,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3483\/revisions\/3485"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=3483"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=3483"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=3483"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}